Every overreaction pathway has the same four joints. The trigger is the antigen or danger signal that starts the response. The second signal is costimulation for lymphocytes or a cytokine for innate cells; without it, activation does not proceed. The effector step is what actually damages tissue: antibody and complement, cytotoxic killing, mast cell mediators, or cytokine-driven endothelial injury. The termination step is the negative regulation that normally ends the response. Blocking any joint reduces damage, but the choice depends on which joint is driving the process. In allergy, the trigger and the IgE-mast cell effector step are the accessible joints. In autoimmunity, the failed tolerance checkpoint means the second signal is being delivered when it should not be, so restoring regulation or removing the self-reactive clone are the relevant joints. In cytokine storm, the amplification loop itself is the target, so interrupting a cytokine receptor or the cell population that sustains the loop matters more than removing the original trigger.
Deriving an intervention for a cytokine-driven scenario
Suppose a patient has a systemic response with high TNF-\(\alpha\), IL-6, and IL-1β, falling blood pressure, and rising markers of organ injury. The mechanism says the loop is the problem: cytokines act on innate cells and T cells, T cells return IFN-\(\gamma\), and IFN-\(\gamma\) pushes macrophages to release more cytokines. The joints are therefore the cytokine receptors on the responding cells, the responding cell population, and the negative regulators that are being outrun. A mechanistically justified intervention would target one of those joints, for example by blocking a cytokine signal or by restoring negative regulation, rather than simply removing the initial trigger, which by this stage is no longer what sustains the response. The same reasoning applied to an allergic reaction would point instead at the IgE-mast cell effector step, because there the loop is not the problem.
Identifying a plausible intervention point is not the same as showing that a treatment works. A joint can be mechanistically central yet inaccessible, redundant, or too late to change the outcome. The derivation gives a hypothesis about where the process could be interrupted, not a clinical recommendation.